Latest "Impact Cryotherapy, Inc." News Stories - Page: 5

19:02 EDT 17th September 2019 | BioPortfolio

Here are the most relevant search results for "Impact Cryotherapy, Inc." found in our extensive news archives from over 250 global news sources.

More Information about Impact Cryotherapy, Inc. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Impact Cryotherapy, Inc. for you to read. Along with our medical data and news we also list Impact Cryotherapy, Inc. Clinical Trials, which are updated daily. BioPortfolio also has a large database of Impact Cryotherapy, Inc. Companies for you to search.

Showing "Impact Cryotherapy" News Articles 101–125 of 3,900+

Wednesday 11th September 2019

Exercising While Restricting Calories Could be Bad for Bone Health Finds UNC School of Medicine Study

UNC School of Medicine’s Maya Styner, MD, led peer-reviewed research showing that the combination of cutting calories and exercising can make bones smaller and more fragile in animals, whereas exercise on a full-calorie diet has a positive impact on bone health. A new study published today in the Journal of Bone and Mineral Research show

Jiuzhou Pharmaceutical to acquire API Manufacturing Facility in China

Zhejiang Jiuzhou Pharmaceutical Co., Ltd.“Jiuzhou Pharmaceutical, a world leading Active Pharmaceutical Ingredients (API) contract development and manufacturing organization (CDMO) today announced it has entered into a contractual commitment for the purchase of an API manufacturing facility in Changshu Economic Technology Development Zone, Suzhou, China from Suzhou Novartis Pharmaceutical Techno...

A curiosity-driven genetic discovery that should impact cancer treatments

A team of geneticists with a desire to understand the inner workings of genes implicated in cellular identity has discovered new biological targets that may help devise alternative therapies for cancers that are becoming resistant to existing...

3SBio's MSCI ESG Rating Upgraded to BBB, Ranking at the Forefront of the Global Biotechnology Industry

SHANGHAI, Sept. 11, 2019 /PRNewswire/ -- According to Morgan Stanley Capital International's (MSCI) latest set of ESG ratings, 3SBio has been upgraded to BBB status, surpassing that of 61% of companies in the global biotechnology industry. MSCI ESG ratings focus on ESG issues that have a substantial impact on the industry at the environmental, social and corporate governance levels to measur...

Transgender 'conversion therapy' associated with 'severe psychological distress'

A study in JAMA Psychiatry is one of the first to highlight the psychological impact of efforts to change a trans person’s gender identity.

Reminder: Sleep Better Austin & The International Academy of Sleep Announces the Sleep Saves Lives Event in Austin, TX, September 12 – Sleep Apnea Oral Appliances Will Be Given Away for Free

This is a reminder that Sleep Better Austin at Hedgecock Dental is seeking to identify sleep apnea candidates for the Sleep Saves Lives event and will make eight free appliances for patients fitting the required profile for care. The first annual “Sleep Saves Lives” event is coming to Austin, TX, on September 12, 2019. An annual outreach project of the International Academy of Sleep, Sleep ...

Professors examine what influences healthy, sustainable food choices

A team of marketing professors have studied the sensory impact of food and the evolution of healthy eating.

Elder Care Innovator HomeThrive Selects LifePod to Augment Care Services for Family Caregivers and their Aging Loved Ones

Lifepod’s Proactive-Voice Caregiving Service Included as an Added Benefit to HomeThrive Customers BOSTON (PRWEB) September 11, 2019 LifePod® Solutions Inc., the first-ever, proactive-voice caregiving service, today announced that elder care innovator HomeThrive has selected LifePod’s voice-first service for rollout to an initial 100 HomeThrive customers. With over 34 million people servi...

Implementation, Impact, and Updating of Rapid Blood Culture Identification System in a Community Hospital Network, Upcoming Webinar Hosted by Xtalks

This webinar will review the advantages of using rapid molecular technology for the detection of bloodstream infections in a hospital setting and why it is important to have the broadest coverage possible for a molecular test. Learn why this technology is superior to conventional methods and how it can ultimately streamline appropriate therapy for each patient. TORONTO (PRWEB) September 11, 2019 ...

Real Brands, Inc. (RLBD) Announces Completion of Audit

Real Brands, Inc. (OTC: RLBD), announced today that it has completed its PCAOB audited financial statements for the two-year period ending December 31, 2018. This is a significant step in additional transparency for the Company’s shareholders and we intend to file an application to become listed on OTCQB and intend to eventually become a fully reporting company. “We are excited to move forw...

What a primary care network pharmacist really does

Former community pharmacist Danny Bartlett has worked in his new local primary care network for a matter of months, but he is already making an impact on his patients.

Spending Up With Treatment in Hospital-Owned Practices

WEDNESDAY, Sept. 11, 2019 -- Financial integration between physicians and hospitals raises patient spending but does not impact care quality, according to a study published online Sept. 3 in the Journal of General Internal Medicine. Vivian Ho,...

Oregon and Southwest Washington’s Life Science Industry: Positioning for Growth

Oregon Bio 2019: Innovating and Scaling for our Region’s Growth is the annual conference aimed at investors, start-up entrepreneurs, executives, researchers, policymakers and bio-supply chain sector executives, happening Oct. 29 in Portland. #OregonBio2019 In only three minutes, rising-star researchers from high schoolers to post-doctoral investigators will highlight their research to more tha...

Dr. Reddy's Laboratories Announces the Launch of Fosaprepitant for Injection in the U.S. Market

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Fosaprepitant for Injection, the therapeutic generic equivalent of EMEND® (fosaprepitant) for injection, approved by the U.S. Food and Drug Administration (USFDA). “We are pleased to be among the first generics to launch...

Duncan Craig: 'I'm concerned students' scientific acumen is completely ignored'

The chair of the Pharmacy Schools Council on five-year MPharm degrees, apprenticeships and the impact of Brexit on research.

ActivOrtho Announces First U.S. Implant of the Nitinol Continuous Compression Screw

ActivOrtho, Inc. (“ActivOrtho”), having recently received 510(K) clearance by the FDA to market the Continuous Compression Screw System, announced its first human clinical implant. Utilizing a one-piece laser cut nitinol screw design, ActivOrtho’s Active Compression Technology (“ACT”) provides compression as bones readjust or resorb during the healing process. Unlike standard screws, ...

Merck initiates phase 3 programme for evobrutinib in relapsing multiple sclerosis

“Evobrutinib is a potential innovation for people living with MS, as it may offer a novel dual mechanism of action that is thought to impact myeloid cells in The post Merck initiates phase 3 programme for evobrutinib in relapsing multiple sclerosis appeared first on Pharmaceutical Business review.

Foundational Role of Experience in Healthcare Affirmed through Global Trends and Insights

Biennial study from The Beryl Institute reveals that the focus on the human experience in healthcare continues to mature NASHVILLE, Tenn. (PRWEB) September 11, 2019 The Beryl Institute announces the release of the full research report from its latest patient experience benchmarking study, A Call to Action for the Future of Human Experience. The study engaged over 1,000 healthcare organization voi...

Caregiver stress: The crucial, often unrecognized byproduct of chronic disease

There is growing evidence that caregivers of patients with cardiovascular disease (CVD) are vulnerable to developing their own poor cardiovascular health. Investigators report on a proof-of-concept couples-based intervention in a cardiac rehabilitation setting. This intervention has shown potential for reducing caregiver distress, and future studies are evaluating its impact on both caregivers' an...

Medix' commitment to social responsibility endorsed through world leading sustainability accreditation

Medix secures world-class GRI accreditation, underlining its impact on critical sustainability issues such as equality in the healthcare sector and social well-being LONDON and HONG KONG, Sept. 11, 2019 /PRNewswire/ -- Medix Group ("Medix" or the "Company"), a leading provider of innovative, high quality he...

Artelo Biosciences to Present at the Fall Investor Summit in New York City on September 17th

LA JOLLA, CA / ACCESSWIRE / September 11, 2019 / Artelo Biosciences, Inc. (NASDAQ:ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate the endocannabinoid system, announced today that it will be presenting at the 2019 Fall Investor Summit being held on September 16th-17th at the Essex House in New York City. The Fall Investor Summit will featur...

Impact of hypertension phenotypes on the office and 24-h pulse wave velocity and augmentation index in individuals with or without antihypertensive medication use

Tuesday 10th September 2019

Mediaplanet and SHRM Chief Human Resources Officer Sean Sullivan Partner to Discuss the Impact of Company Culture and Managerial Relationships on Employee Wellbeing

NEW YORK (PRWEB) September 10, 2019 Using the expertise of industry leaders to explore solutions to problems facing the ever-changing corporate landscape, Mediaplanet today announces the launch of its September, open enrollment edition of their campaign, “Employee Benefits and Engagement.” Wi...

Lung tumorspheres reveal cancer stem cell-like properties and a score with prognostic impact in resected non-small-cell lung cancer

Purdue Pharma has tried to refute accusations that it fueled the opioid crisis. But a new analysis of government data shows that the company, the maker of OxyContin, had a far bigger impact than it portrays. 

Purdue Pharma has tried to refute accusations that it fueled the opioid crisis. But a new analysis of government data shows that the company, the maker of OxyContin, had a far bigger impact than it portrays. 

Quick Search

News Quicklinks